You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Exemestane - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for exemestane and what is the scope of patent protection?

Exemestane is the generic ingredient in two branded drugs marketed by Pfizer, Alvogen, Amneal Pharms, Breckenridge, Cipla, Dr Reddys Labs Sa, Eugia Pharma, Hikma, Qilu, Rising, Upsher Smith Labs, and Zydus Pharms, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for exemestane. Thirteen suppliers are listed for this compound.

Summary for exemestane
Drug Prices for exemestane

See drug prices for exemestane

Recent Clinical Trials for exemestane

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Breast Cancer Research FoundationPhase 2
QuantumLeap Healthcare CollaborativePhase 2
NRG OncologyPhase 2

See all exemestane clinical trials

Pharmacology for exemestane
Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors

US Patents and Regulatory Information for exemestane

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Qilu EXEMESTANE exemestane TABLET;ORAL 213547-001 Apr 13, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Upsher Smith Labs EXEMESTANE exemestane TABLET;ORAL 209208-001 Jul 26, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma EXEMESTANE exemestane TABLET;ORAL 077431-001 Apr 1, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alvogen EXEMESTANE exemestane TABLET;ORAL 200898-001 Jul 28, 2014 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.